Cataract News and Research

Latest Cataract News and Research

HOYA Group's Vision Care Division expands operations in Romania

HOYA Group's Vision Care Division, a key player in the global market for ophthalmic lenses, announces the start of HOYA Lens Romania.

21 Oct 2013

Alimera Sciences receives Complete Response Letter for New Drug Application from FDA

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).

19 Oct 2013

Statins may increase risk of cataracts among individuals above 30 years old

According to the Centers for Disease Control and Prevention, cataracts are the number one cause of vision loss in the United States. Nearly 22 million Americans age 40 and over have cataracts, while more than half of individuals age 80 and over suffer from this condition. In a recent study released in JAMA Ophthalmology, it was confirmed that statins, which are typically prescribed to reduce cholesterol and also prevent heart disease, may cause an increased risk for cataracts among individuals ages 30 through 85.

14 Oct 2013

Mayo Clinic study: Baby boomers to witness surge in cataract surgeries

As baby boomers enter their retirement years, health care costs for complex and debilitating conditions such as Alzheimer's disease are expected to soar. Not drawing as much attention is the likelihood of similarly rising expenses for common age-related medical procedures. A Mayo Clinic study looked at one of those -- cataract surgery-- and found that more people are getting the vision-improving procedure, seeking it at younger ages and having both eyes repaired within a few months, rather than only treating one eye.

10 Oct 2013

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Amgen today announced that it will present data from several romosozumab and Prolia® (denosumab) studies at the American Society for Bone and Mineral Research (ASBMR) 2013 Annual Meeting in Baltimore from Oct. 4-7, 2013.

5 Oct 2013

Short-term hearing loss during childhood may lead to persistent hearing deficits

Short-term hearing loss during childhood may lead to persistent hearing deficits, long after basic auditory sensitivity has returned to normal. The processing of sound in the brain is shaped by early experience.

1 Oct 2013

Optic flow enables perception despite blur image

Blurred images that are unidentifiable as still pictures become understandable once the images are set in motion. That's because of a phenomenon called "optic flow"—which may be especially relevant as a source of visual information in people with low vision, reports a study 'With an Eye to Low Vision: Optic Flow Enables Perception Despite Image Blur' in the October issue of Optometry and Vision Science official journal of the American Academy of Optometry.

27 Sep 2013

IRIDEX's MicroPulse Laser Therapy to be featured at EURETINA and ESCRS conferences

IRIDEX today announced a number of key international conferences and workshops that will feature its proprietary MicroPulse Laser Therapy for the treatment of diabetes and glaucoma related disorders.

26 Sep 2013

Hoopes Vision surgeon implants first light adjustable intraocular artificial lens

On September 4th Dr. Phillip C. Hoopes, Jr., a surgeon at Hoopes Vision, successfully placed a light adjustable intraocular lens implant in a cataract patient as part of a new FDA clinical study.

21 Sep 2013

New analysis finds ASCs provide billions of dollars to Medicare program and its beneficiaries

A new analysis by researchers at the prominent University of California-Berkeley Nicholas C. Petris Center on Health Care Markets and Consumer Welfare finds that ambulatory surgery centers (ASCs) provide billions of dollars in savings to the Medicare program and its beneficiaries.

12 Sep 2013

Omeros seeks EMA's approval to market OMS302 for patients undergoing ILR surgery

Omeros Corporation today announced that it recently submitted a Marketing Authorization Application to the European Medicines Agency seeking approval to market OMS302 for use in patients undergoing intraocular lens replacement surgery in the European Union.

10 Sep 2013

Study: People with cataract-related vision loss who undergo cataract surgery live longer

People with cataract-related vision loss who have had cataract surgery to improve their sight are living longer than those with visual impairment who chose not to have the procedure, according to an Australian cohort study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. After comparing the two groups, the researchers found a 40 percent lower long-term mortality risk in those who had the surgery.

5 Sep 2013

Meta-analysis indicates protective effect of statins in preventing cataracts

Cataracts are the leading cause of visual impairment worldwide affecting more than 20 million people. Statins are among the most commonly prescribed medications. In the USA they are prescribed to 1 in 3 people over 45 years of age at a cost of $35 billion annually.

2 Sep 2013

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO).

29 Aug 2013

Study reveals elegant circuit in visual system helps dictate how eyes connect to brain

A study in mice reveals an elegant circuit within the developing visual system that helps dictate how the eyes connect to the brain. The research, funded by the National Institutes of Health, has implications for treating amblyopia, a vision disorder that occurs when the brain ignores one eye in favor of the other.

26 Aug 2013

STAAR Surgical receives regulatory approval for its Visian ICL with CentraFLOW technology in India

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it has received regulatory approval to market its Visian Implantable Collamer Lens (ICL) with CentraFLOW technology from the CDSCO in India.

19 Aug 2013

Oraya Therapy Stereotactic Radiotherapy for treatment of wet AMDs now available at Optegra

Oraya Therapeutics, Inc. announced today that the Oraya Therapy Stereotactic Radiotherapy for the treatment of wet age-related macular degeneration (AMD) is now available at Optegra Manchester Eye Hospital, becoming the second facility in the UK to provide the therapy.

14 Aug 2013

Omeros announces financial results for second quarter of 2013

Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.

12 Aug 2013

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.

6 Aug 2013

NIH-funded study of aquaporin proteins could hold clues to cataract

Researchers have achieved dynamic, atomic-scale views of a protein needed to maintain the transparency of the lens in the human eye. The work, funded in part by the National Institutes of Health, could lead to new insights and drugs for treating cataract and a variety of other health conditions.

6 Aug 2013

Cataract News and Research

Latest Cataract News and Research

HOYA Group's Vision Care Division expands operations in Romania

Alimera Sciences receives Complete Response Letter for New Drug Application from FDA

Statins may increase risk of cataracts among individuals above 30 years old

Mayo Clinic study: Baby boomers to witness surge in cataract surgeries

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Short-term hearing loss during childhood may lead to persistent hearing deficits

Optic flow enables perception despite blur image

IRIDEX's MicroPulse Laser Therapy to be featured at EURETINA and ESCRS conferences

Hoopes Vision surgeon implants first light adjustable intraocular artificial lens

New analysis finds ASCs provide billions of dollars to Medicare program and its beneficiaries

Omeros seeks EMA's approval to market OMS302 for patients undergoing ILR surgery

Study: People with cataract-related vision loss who undergo cataract surgery live longer

Meta-analysis indicates protective effect of statins in preventing cataracts

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

Study reveals elegant circuit in visual system helps dictate how eyes connect to brain

STAAR Surgical receives regulatory approval for its Visian ICL with CentraFLOW technology in India

Oraya Therapy Stereotactic Radiotherapy for treatment of wet AMDs now available at Optegra

Omeros announces financial results for second quarter of 2013

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

NIH-funded study of aquaporin proteins could hold clues to cataract

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Cataract News and Research

Latest Cataract News and Research

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Newsletters you may be interested in